G1G trading today higher at 0.3, an increase of 0% from yesterday's close, completing a monthly increase of 0% or 0. Over the past 12 months, G1G stock gained 40.566%.
G1G is not paying dividends to its shareholders.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zelira Therapeutics Limited has completed 1 stock splits, with the recent split occurring on Apr 14, 2022.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on ASX (AUD).